摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

sodium (Z)-9-octadecene-1-sulfate | 1847-55-8

中文名称
——
中文别名
——
英文名称
sodium (Z)-9-octadecene-1-sulfate
英文别名
sodium oleyl sulfate;sulfuric acid mono-octadec-9c-enylester; sodium-salt;Schwefelsaeure-mono-octadec-9c-enylester; Natrium-Salz;sodium (Z)-octadec-9-enyl sulphate;sodium;[(Z)-octadec-9-enyl] sulfate
sodium (Z)-9-octadecene-1-sulfate化学式
CAS
1847-55-8
化学式
C18H35O4S*Na
mdl
——
分子量
370.529
InChiKey
MWZFQMUXPSUDJQ-KVVVOXFISA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    24
  • 可旋转键数:
    17
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    74.8
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2920909090

SDS

SDS:850f2e4f308194477fccdf69243b07cd
查看

反应信息

  • 作为产物:
    描述:
    油醇氨基磺酸尿素 、 sodium hydroxide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 sodium (Z)-9-octadecene-1-sulfate
    参考文献:
    名称:
    高双键保留油基硫酸钠的制备、吸附及聚集行为
    摘要:
    以氨基磺酸为硫酸化试剂成功制备了双键保留率高达95.69%的油基硫酸钠(SOS-95),并通过傅里叶变换红外(FT-IR)和氢核磁共振光谱对其结构进行了鉴定(1核磁共振)。与双键保留率为77.38%的十八烷基硫酸钠(OSS)和油基硫酸钠(SOS-77)相比,分析了其平衡表面张力、动态表面张力和动态接触角等表面性质。结果表明,SOS-95具有较低的表面张力(γ CMC) 为 31.96 mN/m,下临界胶束浓度 (CMC) 为 0.028 mmol/L。此外,它具有良好的吸附、扩散和较好的铺展性能,130 s内接触角可低至56.87°。通过透射电子显微镜 (TEM) 研究聚集行为,并通过动态光散射 (DLS) 分析聚集体的大小。结果表明,SOS-95的水溶液在CMC处自发形成球形胶束,浓度越高,聚集体的尺寸越大。偏光显微镜 (POM) 结合小角 X 射线散射 (SAXS) 分析证实,在 SOS-95
    DOI:
    10.1016/j.molliq.2021.117506
点击查看最新优质反应信息

文献信息

  • BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
    申请人:SENOMYX, INC.
    公开号:US20160376263A1
    公开(公告)日:2016-12-29
    The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.
    本发明涵盖已知用于改变苦味感知的化合物和组合物,以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种:冷却剂;无活性药物成分;活性药用成分;食品添加剂或食品;调味剂或调味增强剂;食品或饮料产品;苦味化合物;甜味剂;苦味剂;酸味调味剂;咸味调味剂;鲜味调味剂;植物或动物产品;已知用于宠物护理产品中的化合物;已知用于个人护理产品中的化合物;已知用于家用产品中的化合物;制药制剂;局部制剂;大麻衍生或与大麻相关的产品;已知用于口腔护理产品中的化合物;饮料;香味、香水或除臭剂;已知用于消费品中的化合物;硅化合物;磨料;表面活性剂;发热剂;吸烟物品;脂肪、油脂或乳化剂;和/或益生菌或补充剂。
  • SKIN EXTERNAL PREPARATIONS AND COSMETICS
    申请人:Aoki Hirobumi
    公开号:US20100280111A1
    公开(公告)日:2010-11-04
    An object of the present invention is to provide skin external preparations and cosmetics which contain a branched acyl carnitine and have excellent formulation stability. A skin external preparation of the present invention includes a carnitine derivative represented by the following Formula (1) and/or a carnitine derivative salt represented by the following Formula (2), and an amphoteric surfactant. In Formula (1), R 1 and R 2 are each independently a C1-18 optionally branched, saturated or unsaturated aliphatic hydrocarbon group. In Formula (2), R 1 and R 2 are the same as in Formula (1), X − is a specific anion and Y + is a specific cation.
    本发明的一个目的是提供含有支链酰基肉碱并具有优异配方稳定性的皮肤外用制剂和化妆品。本发明的皮肤外用制剂包括以下式(1)所表示的肉碱衍生物和/或以下式(2)所表示的肉碱衍生物盐,以及一种两性表面活性剂。在式(1)中,R1和R2分别独立地是C1-18的可选支链、饱和或不饱和脂肪烃基。在式(2)中,R1和R2与式(1)中相同,X−是特定的阴离子,Y+是特定的阳离子。
  • SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME
    申请人:Aoki Hirobumi
    公开号:US20100074879A1
    公开(公告)日:2010-03-25
    A skin agent for external use and a cosmetic agent are provided, by transdermal administration of which expected actions and effects of ubiquinone derivatives, salts thereof, ubiquinones and ubiquinols are effectively obtained. The skin agent for external use includes a ubiquinone derivative or a salt thereof as an active ingredient. The ubiquinone derivative is represented by the formula (1): wherein R 1 and R 2 are each a hydrogen atom or a phosphoric group, at least one of R 1 and R 2 is a phosphoric group, and n is an integer in the range of 1 to 9.
    提供了一种外用皮肤剂和化妆品剂,通过经皮给药,可以有效地获得辅酶Q衍生物、其盐、辅酶Q和辅酶QH的预期作用和效果。外用皮肤剂包括辅酶Q衍生物或其盐作为活性成分。辅酶Q衍生物由式(1)表示:其中R1和R2分别是氢原子或磷酸基团,R1和R2中至少有一个是磷酸基团,n是1到9范围内的整数。
  • [EN] A SKIN CARE AND COSMETIC PREPARATION CONTAINING AN INOSITOL DERIVATIVE<br/>[FR] UNE PRÉPARATION COSMÉTIQUE ET DERMATOLOGIQUE CONTENANT UN DÉRIVÉ INOSITOL
    申请人:SHOWA DENKO KK
    公开号:WO2005092285A1
    公开(公告)日:2005-10-06
    The present invention discloses a preparation to be applied externally to the skin which contains an inositol derivative in which an inositol and a saccharide are combined. The invention aims to provide an external skin preparation that can be spread over skin without causing a granular feeling and has excellent moisturising effects and of keeping the skin healthy.
    本发明公开了一种用于外部涂抹于皮肤的制剂,其中包含一种肌醇衍生物,该肌醇衍生物中结合了肌醇和一种糖类。该发明旨在提供一种外用皮肤制剂,可以在皮肤上涂抹而不会产生颗粒感,具有优秀的保湿效果,并保持皮肤健康。
  • FILM FORMING PERSONAL CARE COMPOSITIONS AND METHODS
    申请人:Dong Shaosheng
    公开号:US20130058880A1
    公开(公告)日:2013-03-07
    Compositions, kits and methods of preparing a biocompatible film for cosmetic or medical uses are disclosed. The compositions or kits contain polyvinyl acetal (PVA), siloxane and a solvent. The siloxane can have a hydrophilic group. Once the solvent content is reduced, for instance, by evaporation, the mixture of PVA and siloxane is solidified, forming a film. The compositions and kits, optionally, further include one or more of an antimicrobial agent, a pigment, an anti-inflammatory agent, an anesthetic agent or a hemostatic agent. Such a film can be used, for example, in the form of an antimicrobial sealant, a liquid bandage, body paints, scar camouflage, water-proof sun block, makeup sealer, or antimicrobial wipe or spray.
    揭示了用于化妆品或医疗用途制备生物相容性薄膜的组合物、套件和方法。这些组合物或套件包含聚乙烯醇缩醛(PVA)、硅氧烷和溶剂。硅氧烷可以具有亲水基团。一旦溶剂含量降低,例如通过蒸发,PVA和硅氧烷的混合物会固化,形成薄膜。这些组合物和套件还可以选择性地包含一种或多种抗菌剂、颜料、抗炎剂、麻醉剂或止血剂。这样的薄膜可以用于制作抗菌密封剂、液体创口贴、身体彩绘、疤痕伪装、防水防晒霜、妆前乳、或抗菌擦拭剂或喷雾剂等形式。
查看更多